Article ; Online: Heart failure with improved ejection fraction: Beyond diagnosis to trajectory analysis.
Progress in cardiovascular diseases
2024 Volume 82, Page(s) 102–112
Abstract: Left ventricular (LV) systolic dysfunction represents a highly treatable cause of heart failure (HF). A substantial proportion of patients with HF with reduced ejection fraction (EF;HFrEF) demonstrate improvement in LV systolic function (termed HF with ... ...
Abstract | Left ventricular (LV) systolic dysfunction represents a highly treatable cause of heart failure (HF). A substantial proportion of patients with HF with reduced ejection fraction (EF;HFrEF) demonstrate improvement in LV systolic function (termed HF with improved EF [HFimpEF]), either spontaneously or when treated with guideline-directed medical therapy (GDMT). Although it is a relatively new HF classification, HFimpEF has emerged in recent years as an important and distinct clinical entity. Improvement in LVEF leads to decreased rates of mortality and adverse HF-related outcomes compared to patients with sustained LV systolic dysfunction (HFrEF). While numerous clinical and imaging factors have been associated with HFimpEF, identification of which patients do and do not improve requires further investigation. In addition, patients improve at different rates, and what determines the trajectory of HFimpEF patients after improvement is incompletely characterized. A proportion of patients maintain improvement in LV systolic function, while others experience a recrudescence of systolic dysfunction, especially with GDMT discontinuation. In this review we discuss the contemporary guideline-recommended classification definition of HFimpEF, the epidemiology of improvement in LV systolic function, and the clinical course of this unique patient population. We also offer evidence-based recommendations for the clinical management of HFimpEF and provide a roadmap for future directions in understanding and improving outcomes in the care of patients with HFimpEF. |
---|---|
MeSH term(s) | Humans ; Heart Failure/diagnosis ; Heart Failure/therapy ; Stroke Volume ; Ventricular Function, Left ; Ventricular Dysfunction, Left/diagnostic imaging ; Ventricular Dysfunction, Left/therapy ; Echocardiography |
Language | English |
Publishing date | 2024-01-18 |
Publishing country | United States |
Document type | Journal Article ; Review |
ZDB-ID | 209312-1 |
ISSN | 1873-1740 ; 1532-8643 ; 0033-0620 |
ISSN (online) | 1873-1740 ; 1532-8643 |
ISSN | 0033-0620 |
DOI | 10.1016/j.pcad.2024.01.014 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 229: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.